Daniel Asher bought $970k of CHRN
owner at EKSO BIONICS HOLDINGS, INC.. 102,029 shares at an average of $9.51, traded Feb 6, 2026, filed Feb 17, 2026.
Score components
- +12Role10% owner
- +25Trade size$970k at market
- +10Relative to holdingsHoldings up 65%
- 0Price contextNear the top of the 52-week range
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -6.8%, 3m +39.6%, 6m +110.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001251859-26-000010, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +194 | $9.86 | $1,912 | 156,957 | Feb 17, 2026 |
| Feb 9, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +4,800 | $9.96 | $48k | 161,757 | Feb 17, 2026 |
| Feb 10, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +10,200 | $9.92 | $101k | 171,957 | Feb 17, 2026 |
| Feb 11, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +20,611 | $9.69 | $200k | 192,568 | Feb 17, 2026 |
| Feb 12, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +8,908 | $9.18 | $82k | 201,476 | Feb 17, 2026 |
| Feb 12, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +30,124 | $9.69 | $292k | 231,600 | Feb 17, 2026 |
| Feb 13, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +11,092 | $9.14 | $101k | 242,692 | Feb 17, 2026 |
| Feb 13, 2026 | POpen-market purchase Common Stockindirect: by DBA Trading, LLC | +16,100 | $8.96 | $144k | 258,792 | Feb 17, 2026 |
Related signals
Other insiders at EKSO BIONICS HOLDINGS, INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | EKSO BIONICS HOLDINGS, INC. | Jerome Wong Chief Financial Officer | $15k 1,308 shares | +45% | |
| 34Weak | EKSO BIONICS HOLDINGS, INC. | Jason C Jones Chief Operating Officer | $15k 1,308 shares | +42% | |
| 27Weak | CHRNbuy EKSO BIONICS HOLDINGS, INC. | Daniel Asher owner | $191k 15,540 shares | +6% | |
| 7Weak | CHRNbuy EKSO BIONICS HOLDINGS, INC. | Daniel Asher owner | $12k 1,200 shares | +0% | |
| 20Weak | CHRNsell EKSO BIONICS HOLDINGS, INC. | Jason C Jones Chief Operating Officer | $12k 1,320 shares | -5% | |
| 30Weak | EKSO BIONICS HOLDINGS, INC. | Jerome Wong Chief Financial Officer | $5,819 1,238 shares | -5% | |
| 28Weak | EKSO BIONICS HOLDINGS, INC. | Jason C Jones Chief Operating Officer | $1,269 270 shares | -1% | |
| 55Moderate | EKSO BIONICS HOLDINGS, INC. | Scott G. Davis CEO | $112k 23,315 shares | -23% | |
| 51Moderate | EKSO BIONICS HOLDINGS, INC. | Jason C Jones Chief Operating Officer | $47k 9,723 shares | -26% | |
| 54Moderate | EKSO BIONICS HOLDINGS, INC. | Jerome Wong Chief Financial Officer | $54k 11,288 shares | -30% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.